NASDAQ · Healthcare · Biotechnology
BioNTech SE
BNTX
BioNTech SE, a biotechnology firm, specializes in the creation and marketing of immune-based treatments for malignancies and various infectious diseases. CEO Ugur Sahin · Market cap $23.9B.
$95.25
-0.48 · -0.50%
52w hi $124.0052w lo $79.52
Off 52w high 23.2%
50
ROUTINE
Current InsiderScore
Corp · 90d
24
0 buys · 24 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $121.00
Section 01
Recent Form 4 filings
25 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Oct 07 | Ugur Sahin | Chief Executive Officer | Sell | 24,000 | $95.86 | −$2.30M | 47 |
| Oct 06 | Ugur Sahin | Chief Executive Officer | Sell | 21,000 | $96.81 | −$2.03M | 37 |
| Oct 05 | Ugur Sahin | Chief Executive Officer | Sell | 72,000 | $97.23 | −$7.00M | 50 |
| Oct 02 | Ugur Sahin | Chief Executive Officer | Sell | 17,000 | $96.72 | −$1.64M | 34 |
| Oct 01 | Ugur Sahin | Chief Executive Officer | Sell | 17,000 | $97.46 | −$1.66M | 34 |
| Sep 30 | Ugur Sahin | Chief Executive Officer | Sell | 32,000 | $98.12 | −$3.14M | 37 |
| Sep 29 | Ugur Sahin | Chief Executive Officer | Sell | 34,000 | $98.26 | −$3.34M | 37 |
| Sep 28 | Ugur Sahin | Chief Executive Officer | Sell | 34,000 | $98.47 | −$3.35M | 37 |
| Sep 25 | Ugur Sahin | Chief Executive Officer | Sell | 27,000 | $98.69 | −$2.66M | 34 |
| Sep 24 | Ugur Sahin | Chief Executive Officer | Sell | 39,000 | $98.99 | −$3.86M | 37 |
| Sep 23 | Ugur Sahin | Chief Executive Officer | Sell | 30,000 | $99.40 | −$2.98M | 34 |
| Sep 22 | Ugur Sahin | Chief Executive Officer | Sell | 46,000 | $100.72 | −$4.63M | 37 |
| Sep 21 | Ugur Sahin | Chief Executive Officer | Sell | 33,000 | $97.81 | −$3.23M | 34 |
| Sep 18 | Ugur Sahin | Chief Executive Officer | Sell | 30,000 | $96.22 | −$2.89M | 34 |
| Sep 17 | Ugur Sahin | Chief Executive Officer | Sell | 34,000 | $98.60 | −$3.35M | 34 |
| Sep 16 | Ugur Sahin | Chief Executive Officer | Sell | 15,000 | $96.09 | −$1.44M | 31 |
| Sep 15 | Ugur Sahin | Chief Executive Officer | Sell | 34,000 | $96.49 | −$3.28M | 34 |
| Sep 14 | Ugur Sahin | Chief Executive Officer | Sell | 41,000 | $99.45 | −$4.08M | 34 |
| Sep 11 | Ugur Sahin | Chief Executive Officer | Sell | 45,000 | $96.93 | −$4.36M | 34 |
| Sep 10 | Ugur Sahin | Chief Executive Officer | Sell | 20,500 | $96.31 | −$1.97M | 31 |
| Sep 09 | Ugur Sahin | Chief Executive Officer | Sell | 36,000 | $97.78 | −$3.52M | 31 |
| Sep 08 | Ugur Sahin | Chief Executive Officer | Sell | 37,000 | $99.20 | −$3.67M | 31 |
| Sep 04 | Ugur Sahin | Chief Executive Officer | Sell | 31,500 | $103.52 | −$3.26M | 31 |
| Sep 03 | Ugur Sahin | Chief Executive Officer | Sell | 45,000 | $102.85 | −$4.63M | 34 |
| Apr 22 | Sierk Poetting | Chief Operating Officer | Sell | 50,000 | $110.56 | −$5.53M | 37 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct